Photo of Lloyd Klickstein
Lloyd Klickstein, MD, Ph.D

CEO
Koslapp Therapeutics

Bio

Dr. Klickstein, a rheumatologist and immunologist, has had a long and successful career in the biopharmaceutical industry and biomedical research. Prior to joining Adicet Bio, Inc., he served for thirteen years at Novartis as the Head of NIDU–the unit that researches new drug targets and evaluates them for potential drug development. Prior to his industrial career, he was a physician-scientist for over more than a decade with his own successful lab at Harvard’s BWH where he also had a clinical practice. Dr. Klickstein also serves as an independent Board member at Blade Therapeutics.

Go Back